Immunodeficientmice Archives

Reasons why some cancer cell therapy research is transitioning from CAR-T to CAR-NK.

October 16, 2023

Despite CAR-T cell therapy’s clinical efficacy, it losses target antigen after therapy. NK cells have a spontaneous cytotoxic activity that is effective even when tumour antigen is downregulated.

Preclinical Animal Models for CAR-T Cell Therapy

October 15, 2023

Preclinical Animal Models for CAR-T Cell Therapy Chimeric antigen receptor (CAR)-T cell therapy is one of the leading immunotherapies in oncology. Although many clinical trials

Reasons why some cancer cell therapy research is transitioning from CAR-T to CAR-NK.

Preclinical Animal Models for CAR-T Cell Therapy

HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.

TALK TO A SPECIALIST

EMAIL US

DOCUMENTATION

NEWSLETTER

Our Featured Solutions

SERVICES

RESEARCH FIELD

LEARNING CENTRE

ATLANTIS BIOSCIENCE PTE LTD

Shopping cart

Reasons why some cancer cell therapy research is transitioning from CAR-T to CAR-NK.

Preclinical Animal Models for CAR-T Cell Therapy

HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.

TALK TO A SPECIALIST

EMAIL US

DOCUMENTATION